Decoration of pH-sensitive copolymer micelles with tumor-specific peptide for enhanced cellular uptake of doxorubicin

References

• ChariRVJTargeted cancer therapy: conferring specificity to cytotoxic drugsAcc Chem Res20084119810717705444
   PubMed Web of Science ®Google Scholar
• HuQGaoXGuGGlioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxelBiomaterials201334225640565023639530
   PubMedGoogle Scholar
• SakhraniNMPadhHOrganelle targeting: third level of drug targetingDrug Des Devel Ther20137585
   PubMed Web of Science ®Google Scholar
• HuangKMaHLiuJSize-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivoACS Nano2012654483449322540892
   PubMed Web of Science ®Google Scholar
• FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Del Rev2011633136151
   PubMed Web of Science ®Google Scholar
• IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov Today2006111781281816935749
   PubMed Web of Science ®Google Scholar
• BiswasSTorchilinVPNanopreparations for organelle-specific delivery in cancerAdv Drug Del Rev2014662641
   PubMed Web of Science ®Google Scholar
• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Del Rev201466225
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Del Rev2008601516151626
   PubMed Web of Science ®Google Scholar
• YuBTaiHCXueWLeeLJLeeRJReceptor-targeted nanocarriers for therapeutic delivery to cancerMol Membr Biol201027728629821028937
   PubMed Web of Science ®Google Scholar
• des RieuxAPourcelleVCaniPDMarchand-BrynaertJPréatVTargeted nanoparticles with novel non-peptidic ligands for oral deliveryAdv Drug Del Rev2013656833844
   PubMedGoogle Scholar
• SteinhauserIMLangerKStrebhardtKMSpänkuchBEffect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturationBiomaterials200829294022402818653231
   PubMed Web of Science ®Google Scholar
• SunBRanganathanBFengSSMultifunctional poly (D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancerBiomaterials200829447548617953985
   PubMed Web of Science ®Google Scholar
• BinzHKAmstutzPPlückthunAEngineering novel binding proteins from nonimmunoglobulin domainsNat Biotechnol200523101257126816211069
   PubMed Web of Science ®Google Scholar
• Ruigrok VincentJBLevissonMEppink MichelHMSmidtHvan der OostJAlternative affinity tools: more attractive than antibodies?Biochem J2011436111321524274
   PubMedGoogle Scholar
• BradburyARSidhuSDübelSMcCaffertyJBeyond natural antibodies: the power of in vitro display technologiesNat Biotechnol201129324525421390033
   PubMed Web of Science ®Google Scholar
• OlivierGKChoASaniiBConnollyMDTranHZuckermannRNAntibody-mimetic peptoid nanosheets for molecular recognitionACS Nano20137109276928624016337
   PubMedGoogle Scholar
• ShahinMAhmedSKaurKLavasanifarADecoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxelBiomaterials201132225123513321501865
   PubMed Web of Science ®Google Scholar
• AwadaABozovic-SpasojevicIChowLNew therapies in HER2-positive breast cancer: a major step towards a cure of the disease?Cancer Treat Rev201238549450422305205
   PubMedGoogle Scholar
• ShuklaRThomasTPPetersJLHER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAbBioconjug Chem20061751109111516984117
   PubMed Web of Science ®Google Scholar
• YousefpourPAtyabiFVasheghani-FarahaniEMovahediAADinarvandRTargeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumabInt J Nanomedicine201161977199021976974
   PubMed Web of Science ®Google Scholar
• TaiWMahatoRChengKThe role of HER2 in cancer therapy and targeted drug deliveryJ Control Release2010146326427520385184
   PubMed Web of Science ®Google Scholar
• KouchakzadehHShojaosadatiSATahmasebiFShokriFOptimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticlesInt J Pharm20134471626923454849
   PubMedGoogle Scholar
• BerezovAZhangHTGreeneMIMuraliRDisabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysisJ Med Chem200144162565257411472210
   PubMedGoogle Scholar
• JinYJTermsarasabUKoSHHyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanomaPharm Res201229123443345422886625
   PubMed Web of Science ®Google Scholar
• ChoiKYYoonHYKimJHSmart nanocarrier based on PEGylated hyaluronic acid for cancer therapyACS Nano20115118591859921967065
   PubMed Web of Science ®Google Scholar
• LeeESShinHJNaKBaeYHPoly (l-histidine)–PEG block copolymer micelles and pH-induced destabilizationJ Control Release200390336337412880703
   PubMed Web of Science ®Google Scholar
• QiuLLiZQiaoMSelf-assembled pH-responsive hyaluronic acid–g-poly (l-histidine) copolymer micelles for targeted intracellular delivery of doxorubicinActa Biomater20141052024203524365705
   PubMed Web of Science ®Google Scholar
• QiuLQiaoMChenQEnhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicinBiomaterials201435379877988725201738
   PubMedGoogle Scholar
• AguiarDJKnudsonWKnudsonCBInternalization of the hyaluronan receptor CD44 by chondrocytesExp Cell Res1999252229230210527620
   PubMedGoogle Scholar
• OuastiSKinghamPJTerenghiGTirelliNThe CD44/integrins interplay and the significance of receptor binding and re-presentation in the uptake of RGD-functionalized hyaluronic acidBiomaterials20123341120113422071098
   PubMedGoogle Scholar
• ChoiKYSaravanakumarGParkJHParkKHyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancerColloids Surf B Biointerfaces201299829422079699
   PubMed Web of Science ®Google Scholar
• MochizukiSKanoAShimadaNMaruyamaAUptake of enzymatically-digested hyaluronan by liver endothelial cells in vivo and in vitroJ Biomater Sci Polym Ed2009201839719105902
   PubMed Web of Science ®Google Scholar
• PrevoRBanerjiSFergusonDJClasperSJacksonDGMouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endotheliumJ Biol Chem200127622194201943011278811
   PubMed Web of Science ®Google Scholar
• ArimotoJIkuraYSuekaneTExpression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human liversJ Gastroenterol201045331732519908110
   PubMed Web of Science ®Google Scholar
• WrightCAngusBNicholsonSExpression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancerCancer Res1989498208720902564806
   PubMedGoogle Scholar
• BaselgaJClinical trials of Herceptin® (trastuzumab)Eur J Cancer200137182411342196
   PubMed Web of Science ®Google Scholar
• DouSYaoYDYangXZAnti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapyJ Control Release2012161387588322762887
   PubMed Web of Science ®Google Scholar
• LiXDingLXuYWangYPingQTargeted delivery of doxorubicin using stealth liposomes modified with transferrinInt J Pharm2009373111612319429296
   PubMedGoogle Scholar
• ShiCGaoFGaoXLiuYA novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivoBiomed Pharmacother20156919120025661357
   PubMed Web of Science ®Google Scholar
• YinHLeeESKimDLeeKHOhKTBaeYHPhysicochemical characteristics of pH-sensitive poly (L-histidine)-b-poly (ethylene glycol)/poly (L-lactide)-b-poly (ethylene glycol) mixed micellesJ Control Release2008126213013818187224
   PubMed Web of Science ®Google Scholar
• LuoZJiangJpH-sensitive drug loading/releasing in amphiphilic copolymer PAE–PEG: integrating molecular dynamics and dissipative particle dynamics simulationsJ Control Release2012162118519322743107
   PubMedGoogle Scholar
• JohnsonRPJeongYIJohnJVDual stimuli-responsive poly (N-isopropylacrylamide)-b-poly (L-histidine) chimeric materials for the controlled delivery of doxorubicin into liver carcinomaBiomacromolecules20131451434144323627834
   PubMed Web of Science ®Google Scholar
• LiJHuoMWangJRedox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxelBiomaterials20123372310232022166223
   PubMed Web of Science ®Google Scholar
• ChoHJYoonISYoonHYPolyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicinBiomaterials20123341190120022074664
   PubMed Web of Science ®Google Scholar
• QiuLHuQChengLcRGDyK modified pH responsive nanoparticles for specific intracellular delivery of doxorubicinActa Biomater20163028529826602824
   PubMed Web of Science ®Google Scholar
• LiaoLBZhouHYXiaoXMSpectroscopic and viscosity study of doxorubicin interaction with DNAJ Mol Struct20057491108113
   Google Scholar